T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
Centre for the AIDS Programme of Research in South Africa · Massachusetts General Hospital · +9 more institutions
Abstract
The SARS-CoV-2 Omicron variant (B.1.1.529) contains mutations that mediate escape from antibody responses, although the extent to which these substitutions in spike and non-spike proteins affect T cell recognition is unknown. In this study, we show that T cell responses in individuals with prior infection, vaccination, both prior infection and vaccination, and boosted vaccination are largely preserved to Omicron spike and non-spike proteins. However, we also identify a subset of individuals (∼21%) with a >50% reduction in T cell reactivity to the Omicron spike. Evaluation of functional CD4+ and CD8+ memory T cell responses confirmed these findings and revealed that reduced recognition to Omicron spike is…
Citation impact
- FWCI
- 25.30
- Percentile
- 100%
- References
- 42
Authors
20- VNVivek NaranbhaiCorresponding
Centre for the AIDS Programme of Research in South Africa, Massachusetts General Hospital, Dana-Farber Cancer Institute
- ANAnusha Nathan
Harvard University, Ragon Institute of MGH, MIT and Harvard, Massachusetts Institute of Technology
- CKClarety Kaseke
Ragon Institute of MGH, MIT and Harvard
- CBCristhian Berrios
Massachusetts General Hospital
- AKAshok Khatri
Harvard University, Massachusetts General Hospital
Topics & keywords
- Biology
- Spike (software development)
- Vaccination
- Cell
- Virology
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Coronavirus disease 2019 (COVID-19)
- Genetics
- Good health and well-being